Supersaturating drug delivery system of fixed drug combination: sulfamethoxazole and trimethoprim

References

• Taupitz T, Dressman JB, Klein S. New formulation approaches to improve solubility and drug release from fixed dose combinations: case examples pioglitazone/glimepiride and ezetimibe/simvastatin. Eur J Pharm Biopharm. 2013;84:208–218.
   PubMed Web of Science ®Google Scholar
• Eliopoulos GM, Huovinen P. Resistance to trimethoprim-sulfamethoxazole. Clin Infect Dis [Internet]. 2001;32:1608–1614.
   PubMed Web of Science ®Google Scholar
• Amidon GL, Lennernäs H, Shah VP, et al. A theoretical basis for a biopharmaceutic drug classification: the correlation of in vitro drug product dissolution and in vivo bioavailability. Pharm Res. 1995;12:413–420.
   PubMed Web of Science ®Google Scholar
• Lindenberg M, Kopp S, Dressman JB. Classification of orally administered drugs on the World Health Organization model list of essential medicines according to the biopharmaceutics classification system. Eur J Pharm Biopharm. 2004;58:265–278.
   PubMed Web of Science ®Google Scholar
• Kawabata Y, Wada K, Nakatani M, et al. Formulation design for poorly water-soluble drugs based on biopharmaceutics classification system: basic approaches and practical applications. Int J Pharm. 2011;20:1–10.
   Google Scholar
• Mendes C, Wiemes BP, Buttchevitz A, et al. Investigation of β-cyclodextrin-norfloxacin inclusion complexes. Part 1. Preparation, physicochemical and microbiological characterization. Expert Rev Anti Infect Ther. 2015;13:119–129.
   PubMed Web of Science ®Google Scholar
• Rai M, Ingle AP, Paralikar P. Sulfur and sulfur nanoparticles as potential antimicrobials: from traditional medicine to nanomedicine. Expert Rev Anti Infect Ther. 2016;14:969–978.
   PubMed Web of Science ®Google Scholar
• Alavi M, Rai M. Recent advances in antibacterial applications of metal nanoparticles (MNPs) and metal nanocomposites (MNCs) against multidrug-resistant (MDR) bacteria. Expert Rev Anti Infect Ther. 2019;17:419–428.
   PubMed Web of Science ®Google Scholar
• Arca HÇ, Mosquera-Giraldo LI, Pereira JM, et al. Rifampin stability and solution concentration enhancement through amorphous solid dispersion in cellulose ω-carboxyalkanoate matrices. J Pharm Sci. 2018;107:127–138.
   PubMed Web of Science ®Google Scholar
• Ilevbare GA, Liu H, Edgar KJ, et al. Understanding polymer properties important for crystal growth inhibition-impact of chemically diverse polymers on solution crystal growth of ritonavir. Cryst Growth Des. 2012;12:3133–3143.
   Web of Science ®Google Scholar
• Laitinen R, Lob̈mann K, Strachan CJ, et al. Emerging trends in the stabilization of amorphous drugs. Int J Pharm. 2013;453:65–79.
   PubMed Web of Science ®Google Scholar
• Vo CL-N, Park C, Lee B-J. Current trends and future perspectives of solid dispersions containing poorly water-soluble drugs. Eur J Pharm Biopharm [Internet]. 2013;85:799–813. Available from: http://linkinghub.elsevier.com/retrieve/pii/S0939641113003007
   PubMed Web of Science ®Google Scholar
• Alhalaweh A, Alzghoul A, Kaialy W, et al. Computational predictions of glass-forming ability and crystallization tendency of drug molecules. Mol Pharm. 2014;11:3123–3132.
   PubMed Web of Science ®Google Scholar
• Singh A, Van den Mooter G. Spray drying formulation of amorphous solid dispersions. Adv Drug Deliv Rev. 2016;100:27–50.
   PubMed Web of Science ®Google Scholar
• Leuner C, Dressman J. Improving drug solubility for oral delivery using solid dispersions. Eur J Pharm Biopharm [Internet]. 2000;50:47–60. Available from: http://www.ncbi.nlm.nih.gov/pubmed/10840192
   PubMed Web of Science ®Google Scholar
• França MT, Nicolay RP, Klüppel Riekes M, et al. Investigation of novel supersaturating drug delivery systems of chlorthalidone: the use of polymer-surfactant complex as an effective carrier in solid dispersions. Eur J Pharm Sci [Internet]. 2018;111:142–152.
   PubMed Web of Science ®Google Scholar
• Paudel A, Worku ZA, Meeus J, et al. Manufacturing of solid dispersions of poorly water soluble drugs by spray drying: formulation and process considerations. Int J Pharm. 2013;453:253–284.
   PubMed Web of Science ®Google Scholar
• Zhou D, He S, Cong Y, et al. A polymer-(multifunctional single-drug) conjugate for combination therapy. J Mater Chem B. 2015;3:4913–4921.
   Web of Science ®Google Scholar
• Jackson MJ, Kestur US, Hussain MA, et al. Characterization of supersaturated danazol solutions - impact of polymers on solution properties and phase transitions. Pharm Res. 2016;33:1276–1288.
   Web of Science ®Google Scholar
• Indulkar AS, Mo H, Gao Y, et al. Impact of micellar surfactant on supersaturation and insight into solubilization mechanisms in supersaturated solutions of atazanavir. Pharm Res. 2017;34:1–20.
   PubMed Web of Science ®Google Scholar
• Xie T, Gao W, Taylor LS. Impact of Eudragit EPO and hydroxypropyl methylcellulose on drug release rate, supersaturation, precipitation outcome and redissolution rate of indomethacin amorphous solid dispersions. Int J Pharm. 2017;531:313–323.
   PubMed Web of Science ®Google Scholar
• Munari J, Pinto O, Leão AF, et al. HPMCAS as an effective precipitation inhibitor in amorphous solid dispersions of the poorly soluble drug candesartan cilexetil. Carbohydr Polym 2017;184:199–206.
   Google Scholar
• ICH guidelines. Q2(R1): validation of analytical procedures : text and methodology. Int Conf Harmon. 2005;1994:17.
   Google Scholar
• CLSI. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically [Internet]. Approv Stand Ed CLSI Doc. M07-A10. 2015. Available from: http://shop.clsi.org/site/Sample_pdf/M07A10_sample.pdf
   Google Scholar
• Lehár J, Krueger AS, Avery W, et al. Synergistic drug combinations tend to improve therapeutically relevant selectivity. Nat Biotechnol. 2009;27:659–666.
   PubMed Web of Science ®Google Scholar
• Tyers M, Wright GD. Drug combinations: a strategy to extend the life of antibiotics in the 21st century. Nat Rev Microbiol. 2019;17:141–155.
   PubMed Web of Science ®Google Scholar
• Fule R, Dhamecha D, Maniruzzaman M, et al. Development of hot melt co-formulated antimalarial solid dispersion system in fixed dose form (ARLUMELT): evaluating amorphous state and in vivo performance. Int J Pharm. 2015;496:137–156.
   PubMedGoogle Scholar
• Mondal R, Ghosh N, Mukherjee S. Enhanced binding of phenosafranin to triblock copolymer F127 induced by sodium dodecyl sulfate: a mixed micellar system as an efficient drug delivery vehicle. J Phys Chem B. 2016;120:2968–2976.
   PubMed Web of Science ®Google Scholar
• Tanzadehpanah H, Mahaki H, Samadi P, et al. Anticancer activity, calf thymus DNA and human serum albumin binding properties of Farnesiferol C from Ferula pseudalliacea. J Biomol Struct Dyn. 2018;37: 2789–2800.
   Web of Science ®Google Scholar
• Bae Y, Kataoka K. Intelligent polymeric micelles from functional poly(ethylene glycol)-poly(amino acid) block copolymers. Adv Drug Deliv Rev. 2009;61:768–784.
   PubMed Web of Science ®Google Scholar
• Taylor LS, Zhang GGZ. Physical chemistry of supersaturated solutions and implications for oral absorption. Adv Drug Deliv Rev. 2016;101:122–142.
   PubMed Web of Science ®Google Scholar
• Miller JM, Beig A, Carr RA, et al. A win–win solution in oral delivery of lipophilic drugs: supersaturation via amorphous solid dispersions increases apparent solubility without sacrifice of intestinal membrane permeability. Mol Pharm [Internet]. 2012;9:2009–2016.
   PubMed Web of Science ®Google Scholar
• Chang YP, Tang M, Chen YP. Micronization of sulfamethoxazole using the supercritical anti-solvent process. J Mater Sci. 2008;43:2328–2335.
   Web of Science ®Google Scholar
• Choonara BF, Choonara YE, Kumar P, et al. A menthol-based solid dispersion technique for enhanced solubility and dissolution of sulfamethoxazole from an oral tablet matrix. AAPS Pharm Sci Tech. 2014;16: 771–786.
   PubMed Web of Science ®Google Scholar
• Saraf A, Sharma S, Sachar S. Insights into the interactions of sulfamethoxazole with organized assemblies of ionic and nonionic surfactants. Langmuir [Internet]. 2018;34:14624–14632.
   PubMed Web of Science ®Google Scholar
• Garnero C, Aiassa V, Longhi M. Sulfamethoxazole: hydroxypropyl-β-cyclodextrin complex: preparation and characterization. J Pharm Biomed Anal. 2012;63:74–79.
   PubMed Web of Science ®Google Scholar
• Varghese B, Suliman FEO, Al-Hajri A, et al. Spectral and theoretical study on complexation of sulfamethoxazole with β- and HPβ-cyclodextrins in binary and ternary systems. Spectrochim Acta Part A Mol Biomol Spectrosc. 2018;190:392–401.
   PubMed Web of Science ®Google Scholar
• Figueiras A, Cardoso O, Veiga F, et al. Preparation and characterization of trimethoprim inclusion complex with methyl-β-cyclodextrin and determination of its antimicrobial activity. Pharm Anal Acta. 2015;6:6–10.
   Google Scholar
• Hernández D, Lazo L, Valdés L, et al. Synthetic clay mineral as nanocarrier of sulfamethoxazole and trimethoprim. Appl Clay Sci [Internet]. 2018;161:395–403.
   Web of Science ®Google Scholar
• Sarode AL, Wang P, Obara S, et al. Supersaturation, nucleation, and crystal growth during single- and biphasic dissolution of amorphous solid dispersions: polymer effects and implications for oral bioavailability enhancement of poorly water soluble drugs. Eur J Pharm Biopharm [Internet]. 2014;86:351–360.
   PubMed Web of Science ®Google Scholar
• Yu L. Amorphous pharmaceutical solids: preparation, characterization and stabilization. Adv Drug Deliv Rev. 2001;48:27–42.
   PubMed Web of Science ®Google Scholar
• Vijaya Chamundeeswari SP, James Jebaseelan Samuel E, Sundaraganesan N. Molecular structure, vibrational spectra, NMR and UV spectral analysis of sulfamethoxazole. Spectrochim Acta Part A Mol Biomol Spectrosc. 2014;118:1–10.
   PubMed Web of Science ®Google Scholar
• Maddileti D, Swapna B, Nangia A. Tetramorphs of the antibiotic drug trimethoprim: characterization and stability. Cryst Growth Des. 2015;15:1745–1756.
   Web of Science ®Google Scholar
• Djellouli F, Dahmani A, Hassani A. Characterization of the polymorph changes in trimethoprim. J Therm Anal Calorim. 2017;130:1585–1591.
   Web of Science ®Google Scholar
• Mahlin D, Bergström CAS. Early drug development predictions of glass-forming ability and physical stability of drugs. Eur J Pharm Sci. [Internet]. 2013;49:323–332.
   PubMed Web of Science ®Google Scholar
• Altamimi MA, Neau SH. Use of the flory–huggins theory to predict the solubility of nifedipine and sulfamethoxazole in the triblock, graft copolymer soluplus. Drug Dev Ind Pharm. 2016;42:446–455.
   PubMed Web of Science ®Google Scholar
• Baird JA, Taylor LS. Evaluation of amorphous solid dispersion properties using thermal analysis techniques. Adv Drug Deliv Rev. 2012;64:396–421.
   PubMed Web of Science ®Google Scholar
• Meng F, Dave V, Chauhan H. Qualitative and quantitative methods to determine miscibility in amorphous drug-polymer systems. Eur J Pharm Sci. 2015;77:106–111.
   PubMed Web of Science ®Google Scholar
• Price CP, Grzesiak AL, Matzger AJ. Crystalline polymorph selection and discovery with polymer heteronuclei. J Am Chem Soc. 2005;127:5512–5517.
   PubMed Web of Science ®Google Scholar